By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported that its fourth-quarter revenues declined 16 percent year over year, missing analysts' consensus estimate.

The Cincinnati-based diagnostics firm brought in total revenues of $35.5 million for the three months ended Sept. 30, compared to $42.5 million for the fourth quarter of 2009. It missed analysts' consensus estimate of $38.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.